Trials / Unknown
UnknownNCT02804529
A Comparison of Three Different Entry Points to Establish the Pneumoperitoneum
A Comparison of Three Different Puncture Points to Establish the Pneumoperitoneum in Laparoscopic Gastrointestinal Surgery: A Randomized Prospective Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- China-Japan Friendship Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The Palmer's point and periumbilical region are the common laparoscopic entry site to establish the pneumoperitoneum. In the present study, the investigators assess the safety and feasibility of Meng's point as a new laparoscopic entry site in cases to perform the gastrointestinal surgery. This prospective and randomized study will compare the three entry techniques with regard to: * Complications related to the entry technique * Time taken to enter the abdomen. * The number of attempts taken to enter the abdomen
Detailed description
Patients of China-Japan Friendship Hospital that are having a laparoscopic surgery for general surgery purposes will participate in the study. Patients with previous abdominal surgeries will be excluded from the study. A patient information sheet will be provided and written consent will be obtained. Patients who give written consent will be randomized into the three arms of the trial. All patient information will be confidential and only be available to researches involved in the study. Only one attending surgeon of the General Surgery Department of China-Japan Friendship Hospital will participate in the study. 90 patients will be recruited over one year period and the data will be analysed by a statistician.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Veress needle |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2018-06-01
- Completion
- 2018-09-01
- First posted
- 2016-06-17
- Last updated
- 2018-02-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02804529. Inclusion in this directory is not an endorsement.